Importance: Diabetic retinopathy (DR) is a leading cause of vision loss that is managed primarily through qualitative clinical examination of the retina. Optical coherence tomography angiography (OCTA) may offer an objective and quantitative method of evaluating DR. Objective: To quantify capillary nonperfusion in 3 vascular plexuses in the macula of eyes patients with diabetes of various retinopathy severity using projection-resolved OCTA (PR-OCTA). Design, Setting, and Participants: Cross-sectional study at a tertiary academic center comprising 1 eye each from healthy control individuals and patients with diabetes at different severity stages of retinopathy. Data were acquired and analyzed between January 2015 and December 2017. Main Outcomes and Measures: Foveal avascular zone area, extrafoveal avascular area (EAA), and the sensitivity of detecting levels of retinopathy. Results: The study included 39 control individuals (20 women [51%]; mean [SD] age, 43.41 [19.37] years); 16 patients with diabetes without retinopathy (8 women [50%]; mean [SD] age, 56.50 [12.43] years); 23 patients with mild to moderate nonproliferative DR (18 women [78%] ; mean [SD] age, 62.48 [10.55] years); and 32 patients with severe nonproliferative DR or proliferative DR (12 women [38%]; mean age, 53.41 [14.05] years). Mean (SD) foveal avascular zone area was 0.203 (0.103) mm2 for control individuals, 0.192 (0.084) mm2 for patients with diabetes without retinopathy, 0.243 [0.079] mm2 for mild to moderate nonproliferative DR, and 0.359 (0.275) mm2 for severe nonproliferative DR or proliferative DR. Mean (SD) EAA in whole inner retinal slab in these groups, respectively, were 0.020 (0.031) mm2, 0.034 (0.047) mm2, 0.038 (0.040) mm2, and 0.237 (0.235) mm2. The mean (SD) sum of EAA from 3 segmented plexuses in each of the respective groups were 0.103 (0.169) mm2, 0.213 (0.242) mm2, 0.451 (0.243) mm2, and 1.325 (1.140) mm2. With specificity fixed at 95%, using EAA in inner retinal slab, the sensitivity of detecting patients with diabetes from healthy control individuals was 28% (95% CI, 18%-40%), 31% for patients with DR (95% CI, 19%-45%), and 47% for patients with severe DR (95% CI, 29%-65%) from whole inner retinal EAA. With the sum of EAA from 3 individual plexuses, the sensitivities were 69% (95% CI, 57%-80%), 82% (95% CI, 70%-91%), and 97% (95% CI, 85%-100%), respectively. Avascular areas were not associated with signal strength index. The commercial vessel density from the 2-plexus scheme distinguished the groups with lower sensitivity and were dependent on SSI. Conclusions and Relevance: Automatically quantified avascular areas from a 3-layer segmentation scheme using PR-OCTA distinguished levels of retinopathy with a greater sensitivity than avascular areas from unsegmented inner retinal slab or measurements from a commercially available vessel density in 2-layer scheme. Additional studies are needed to investigate the applicability of nonperfusion parameters in clinical settings.
Importance: Diabetic retinopathy (DR) is a leading cause of vision loss that is managed primarily through qualitative clinical examination of the retina. Optical coherence tomography angiography (OCTA) may offer an objective and quantitative method of evaluating DR. Objective: To quantify capillary nonperfusion in 3 vascular plexuses in the macula of eyespatients with diabetes of various retinopathy severity using projection-resolved OCTA (PR-OCTA). Design, Setting, and Participants: Cross-sectional study at a tertiary academic center comprising 1 eye each from healthy control individuals and patients with diabetes at different severity stages of retinopathy. Data were acquired and analyzed between January 2015 and December 2017. Main Outcomes and Measures: Foveal avascular zone area, extrafoveal avascular area (EAA), and the sensitivity of detecting levels of retinopathy. Results: The study included 39 control individuals (20 women [51%]; mean [SD] age, 43.41 [19.37] years); 16 patients with diabetes without retinopathy (8 women [50%]; mean [SD] age, 56.50 [12.43] years); 23 patients with mild to moderate nonproliferative DR (18 women [78%] ; mean [SD] age, 62.48 [10.55] years); and 32 patients with severe nonproliferative DR or proliferative DR (12 women [38%]; mean age, 53.41 [14.05] years). Mean (SD) foveal avascular zone area was 0.203 (0.103) mm2 for control individuals, 0.192 (0.084) mm2 for patients with diabetes without retinopathy, 0.243 [0.079] mm2 for mild to moderate nonproliferative DR, and 0.359 (0.275) mm2 for severe nonproliferative DR or proliferative DR. Mean (SD) EAA in whole inner retinal slab in these groups, respectively, were 0.020 (0.031) mm2, 0.034 (0.047) mm2, 0.038 (0.040) mm2, and 0.237 (0.235) mm2. The mean (SD) sum of EAA from 3 segmented plexuses in each of the respective groups were 0.103 (0.169) mm2, 0.213 (0.242) mm2, 0.451 (0.243) mm2, and 1.325 (1.140) mm2. With specificity fixed at 95%, using EAA in inner retinal slab, the sensitivity of detecting patients with diabetes from healthy control individuals was 28% (95% CI, 18%-40%), 31% for patients with DR (95% CI, 19%-45%), and 47% for patients with severe DR (95% CI, 29%-65%) from whole inner retinal EAA. With the sum of EAA from 3 individual plexuses, the sensitivities were 69% (95% CI, 57%-80%), 82% (95% CI, 70%-91%), and 97% (95% CI, 85%-100%), respectively. Avascular areas were not associated with signal strength index. The commercial vessel density from the 2-plexus scheme distinguished the groups with lower sensitivity and were dependent on SSI. Conclusions and Relevance: Automatically quantified avascular areas from a 3-layer segmentation scheme using PR-OCTA distinguished levels of retinopathy with a greater sensitivity than avascular areas from unsegmented inner retinal slab or measurements from a commercially available vessel density in 2-layer scheme. Additional studies are needed to investigate the applicability of nonperfusion parameters in clinical settings.
Authors: Wasim A Samara; Abtin Shahlaee; Murtaza K Adam; M Ali Khan; Allen Chiang; Joseph I Maguire; Jason Hsu; Allen C Ho Journal: Ophthalmology Date: 2016-11-23 Impact factor: 12.079
Authors: Sonja G Karst; Gabor G Deak; Bianca S Gerendas; Sebastian M Waldstein; Jan Lammer; Christian Simader; Tadhg Guerin; Ursula M Schmidt-Erfurth Journal: JAMA Ophthalmol Date: 2018-04-01 Impact factor: 7.389
Authors: Sarwar Zahid; Rosa Dolz-Marco; K Bailey Freund; Chandrakumar Balaratnasingam; Kunal Dansingani; Fatimah Gilani; Nitish Mehta; Emma Young; Meredith R Klifto; Bora Chae; Lawrence A Yannuzzi; Joshua A Young Journal: Invest Ophthalmol Vis Sci Date: 2016-09-01 Impact factor: 4.799
Authors: Simon S Gao; Yali Jia; Liang Liu; Miao Zhang; Hana L Takusagawa; John C Morrison; David Huang Journal: Invest Ophthalmol Vis Sci Date: 2016-08-01 Impact factor: 4.799
Authors: Giselle Lynch; Jorge S Andrade Romo; Rachel Linderman; Brian D Krawitz; Shelley Mo; Amir Zakik; Joseph Carroll; Richard B Rosen; Toco Y P Chui Journal: Biomed Opt Express Date: 2018-11-05 Impact factor: 3.732
Authors: Liang Liu; Beth Edmunds; Hana L Takusagawa; Shandiz Tehrani; Lorinna H Lombardi; John C Morrison; Yali Jia; David Huang Journal: Am J Ophthalmol Date: 2019-06-03 Impact factor: 5.258
Authors: Tristan T Hormel; Jie Wang; Steven T Bailey; Thomas S Hwang; David Huang; Yali Jia Journal: Biomed Opt Express Date: 2018-11-26 Impact factor: 3.732
Authors: İkbal Şencan; Tatiana V Esipova; Mohammad A Yaseen; Buyin Fu; David A Boas; Sergei A Vinogradov; Mahnaz Shahidi; Sava Sakadžić Journal: J Biomed Opt Date: 2018-12 Impact factor: 3.170
Authors: Mohamed Ashraf; Konstantina Sampani; Allen Clermont; Omar Abu-Qamar; Jae Rhee; Paolo S Silva; Lloyd Paul Aiello; Jennifer K Sun Journal: Invest Ophthalmol Vis Sci Date: 2020-08-03 Impact factor: 4.799